1Introduction

English
Introduction
The VPAP™ III ST-A with QuickNav™ is a bilevel pressure support ventilator specifically
designed for non-invasive mask ventilation.
This user manual contains the information you need for the correct use of your
VPAP III ST-A with QuickNav.

User/Owner Responsibility

The user or owner of this system shall have sole responsibility and liability for any injury to
persons or damage to property resulting from:
•operation which is not in accordance with the operating instructions supplied
•maintenance or modifications carried out unless in accordance with authorised
instructions and by authorised persons.
Please read this manual carefully before use.
This manual contains special terms and icons that appear in the margins to draw your
attention to specific and important information.
•Warning alerts you to possible injury.
•Caution explains special measures for the safe and effective use of the device.
•Note is an informative or helpful note.
Medical Information

Intended Use

The VPAP III ST-A system is intended to provide non-invasive ventilation for patients with
respiratory insufficiency or obstructive sleep apnoea (OSA), in the hospital or home.

Contraindications

This device should not be used if you have an insufficient respiratory drive to endure brief
interruptions in non-invasive ventilation therapy. This device is not a life support ventilator
and may stop operating with power failure or in the unlikely event of certain fault conditions.
If you have any of the following conditions, tell your doctor before using this device:
•acute sinusitis or otitis media
•epistaxis causing a risk of pulmonary aspiration
•conditions predisposing to a risk of aspiration of gastric contents
•impaired ability to clear secretions
•hypotension or significant intravascular volume depletion
•pneumothorax or pneumomediastinum
•recent cranial trauma or surgery.

Adverse Effects

You should report unusual chest pain, severe headache or increased breathlessness to your
physician. An acute upper respiratory tract infection may require temporary discontinuation
of treatment.
The following side effects may arise during the course of therapy:
•drying of the nose, mouth or throat
•bloating
248603 VPAP III ST-A with QuickNav User Guide EUR1.book Page 1 Tuesday, January 17, 2012 11:25 AM